Molecular Cancer Profiling is an advanced diagnostic approach that examines genetic and molecular changes within a cancer to provide a more detailed understanding of the disease. By analyzing tumor tissue, blood, or other clinically appropriate samples, molecular profiling may identify specific biomarkers, gene mutations, and other molecular alterations that can help doctors better understand a patient's cancer.
What Does Molecular Cancer Profiling Identify?
Depending on the cancer type and test used, cancer genomic profiling may assess genetic alterations, actionable mutations, biomarkers, and molecular characteristics associated with tumor growth. The findings can support oncologists in evaluating treatment options and determining whether targeted therapies, immunotherapy, or other approaches may be appropriate.
Who May Benefit?
Molecular profiling may be considered for patients with certain cancers, particularly when standard treatment options are limited, the cancer has returned or progressed, or additional molecular information could help guide treatment decisions. The suitability of testing depends on the cancer type, stage, available tissue, previous treatments, and the treating oncologist's recommendation.